Why Bellicum Pharmaceuticals Stock Is Plunging Today

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) announced the presentation of early Phase 1 results for BPX-601 at the American Society of Clinical Oncology…
  • Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) announced the presentation of early Phase 1 results for BPX-601 at the American Society of Clinical Oncology Genitourinary Cancers Symposium. 
  • These interim results demonstrated the preliminary efficacy of BPX-601 PSCA-directed GoCAR-T cells in combination with rimiducid in heavily pre-treated patients. These initial data from 2 cohorts consisted of 8 patients.
  • Four of eight (50%) patients achieved a PSA50 response, three of whom achieved a PSA90 response.
  • Of the six patients with soft tissue disease, two achieved partial responses.
  • Of the two patients with the bone-only disease, one patient achieved a PSA90 response with a decreased enhancement of bone lesions observed on the bone scan.
  • The most common grade 3+ adverse events were myelosuppression, characteristic of the lymphodepletion chemotherapies used in CAR-T studies. 
  • Two patients experienced Grade 3 cytokine release syndrome (CRS). One patient experienced Grade 4 immune effector cell neurotoxicity syndrome (ICANS) with concurrent hemophagocytic lymphohistiocytosis (HLH). 
  • ICANS improved to grade 1 with the standard of care and withholding subsequent doses of rimiducid, the patient died on study day 20 due to sepsis. 
  • Consistent BPX-601 cell expansion across patients was observed, with the persistence of BPX-601 cells detected in peripheral blood over 200 days.
  • BPX-601 cell infiltration in PSCA-positive tumors was observed. The trial continues to enroll patients.
  • Price Action: BLCM shares are down 12.70% at $1.07 on the last check Thursday.
Total
0
Shares
Related Posts
Read More

Asia And Europe Markets Mixed, Copper Hits Two-Year High, Gold Edges Higher At $2,375 – Global Markets Today While US Slept

On Wednesday, Asian markets, Japan's Nikkei 225 and Australia's S&P/ASX 200 saw gains, while India's Nifty 50 and China's indices experienced a slight dip. Hong Kong markets were closed for a holiday. In the Eurozone, Germany's DAX saw a rise, while France's CAC declined slightly. Commodities saw an increase with Crude Oil WTI and Brent trading higher, and Copper hitting a two-year high due to tight supply and China's fiscal stimulus. Despite some fluctuations, the overall market showed signs of resilience.

ADIV